The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.

被引:79
|
作者
Lundberg I.E. [1 ]
机构
[1] Department of Rheumatology, Karolinska Hospital, Stockholm
关键词
Muscle Tissue; Myositis; Dermatomyositis; Inclusion Body Myositis; Inflammatory Myopathy;
D O I
10.1007/s11926-000-0082-y
中图分类号
学科分类号
摘要
Cytokines, chemokines, and adhesion molecules are important mediators in chronic inflammation and in immune regulation. In idiopathic inflammatory myopathies (IIM), increased expression of proinflammatory cytokines particularly interleukin (IL)-1alpha and IL-1beta, tumor necrosis factor (TNF)-alpha and macrophage inflammatory proteins (MIP)-1alpha, as well as of the inhibitory cytokines transforming growth factor (TGF)-beta was observed in muscle. There was no difference in cytokine and chemokine pattern between polymyositis, dermatomyositis, and inclusion body myositis, which could indicate that similar pathogenetic mechanisms are involved in these subsets of myositis. A prominent finding of IL-1alpha expression in endothelial cells, both in patients with active inflammation and in patients with chronic persisting muscle weakness without inflammation, makes this an interesting molecule in understanding the mechanisms for the pathogenesis of muscle weakness. Involvement of the blood vessels in the pathogenesis of myositis was further supported by increased expression of adhesion molecules and by a phenotypical expression of endothelial cells, resembling high endothelium venules in all three subsets of IIM. The molecular studies to date indicate a role of the microvessels in the pathogenesis of IIM not only in DM, as was previously suggested, but also in PM and IBM. The studies also indicate that IL-1alpha could be a target molecule for new therapeutical interventions.
引用
收藏
页码:216 / 224
页数:8
相关论文
共 50 条
  • [1] Role of cytokines and chemokines in idiopathic inflammatory myopathies
    De Paepe, Boel
    Creus, Kim K.
    De Bleecker, Jan L.
    CURRENT OPINION IN RHEUMATOLOGY, 2009, 21 (06) : 610 - 616
  • [2] Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies
    Figarella-Branger, D
    Civatte, M
    Bartoli, C
    Pellissier, JF
    MUSCLE & NERVE, 2003, 28 (06) : 659 - 682
  • [3] Idiopathic inflammatory myopathies. A review
    Acosta, Ignacio
    Manuel Matamala, Jose
    Jara, Paula
    Pino, Francisca
    Gallardo, Alejandra
    Verdugo, Renato
    REVISTA MEDICA DE CHILE, 2019, 147 (03) : 342 - 355
  • [4] Familial autoimmunity and the idiopathic inflammatory myopathies.
    Shamim E.A.
    Miller F.W.
    Current Rheumatology Reports, 2000, 2 (3) : 201 - 211
  • [5] Pathogenesis of idiopathic inflammatory myopathies
    Grundtman C.
    Lundberg I.E.
    Current Rheumatology Reports, 2006, 8 (3) : 188 - 195
  • [6] Chemokines in idiopathic inflammatory myopathies
    De Paepe, Boel
    Creus, Kim K.
    De Bleecker, Jan L.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 2548 - 2557
  • [7] Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies
    Cecilia Grundtman
    Vivianne Malmström
    Ingrid E Lundberg
    Arthritis Research & Therapy, 9
  • [8] The Emerging Role of Mitochondrial Dysfunction in the Pathogenesis of Idiopathic Inflammatory Myopathies
    Gonzalez-Chapa, Jorge Armando
    Macedo, Marina Barguil
    Lood, Christian
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2023, 14 (02):
  • [9] Outcomes and disease activity measures for assessing treatments in the idiopathic inflammatory myopathies.
    Oddis C.V.
    Current Rheumatology Reports, 2005, 7 (2) : 87 - 93
  • [10] The Role of Immune Cells in the Pathogenesis of Idiopathic Inflammatory Myopathies
    Zhao, Lijuan
    Wang, Qi
    Zhou, Bin
    Zhang, Lihua
    Zhu, Honglin
    AGING AND DISEASE, 2021, 12 (01): : 247 - 260